About: Sandrine Silvente-Poirot

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: Sandrine Silvente-Poirot Goto Sponge NotDistinct Permalink

An Entity of Type : foaf:Person, within Data Space : data.idref.fr associated with source document(s)

Attributes	Values
type	Person
sameAs	Silvente-Poirot, Sandrine Silvente-Poirot, Sandrine Silvente-Poirot, Sandrine
alternative label	Poirot, Sandrine Poirot, Sandrine Silvente (Mme) Poirot-Silvente, Sandrine
preferred label	Silvente-Poirot, Sandrine
name	Sandrine Silvente-Poirot
dbpedia-owl:citizenship	http://sws.geonames.org/3017382/
Language	http://lexvo.org/id/iso639-3/fra
Given name	Sandrine
familyName	Silvente-Poirot
has biographical i...tion (Deprecated)	Directrice de recherche à l'INSERM, Institut national de la santé et de la recherche médicale, Toulouse (en 2001)
gender	female
ORCID iD	0000-0003-2245-9069
Scopus ID	57202560450
is sameAs of	Silvente-Poirot, Sandrine Silvente-Poirot, Sandrine Silvente-Poirot, Sandrine Silvente-Poirot, Sandrine
is Thesis advisor of	http://www.sudoc.fr/228957613/id http://www.sudoc.fr/061099961/id Etude du récepteur aux glucocorticoïdes dans le cancer du sein http://www.sudoc.fr/229038956/id http://www.sudoc.fr/157661660/id http://www.sudoc.fr/14456159X/id http://www.sudoc.fr/156357089/id http://www.sudoc.fr/144518287/id Métabolisme du cholestérol et cancer http://www.sudoc.fr/246593482/id http://www.sudoc.fr/262277719/id Synthèse, évaluation \"in vitro\" et \"in vivo\" de nouveaux radiopharmaceutiques qui ciblent le récepteur de la cholécystokinine/gastrine Etude de l'efficacité de la dendrogénine A sur les cancers de la thyroïde réfractaires à l'iode radioactif 131 http://www.sudoc.fr/247173274/id http://www.sudoc.fr/26228135X/id Développement de nouveaux ligands peptidiques radiomarqués pour l'oncologie nucléaire, application au ciblage tumoral des récepteurs de la cholécystokinine/gastrine Caractérisation des déterminants moléculaires du récepteur CCK2 impliqués dans le site de liaison de la CCK et l'activation du récepteur http://www.sudoc.fr/233735054/id http://www.sudoc.fr/242335276/id Etude du métabolisme du cholestérol dans la progression et la résistance des cancers mammaires et identification de nouvelles cibles thérapeutiques http://www.sudoc.fr/233748806/id http://www.sudoc.fr/247987204/id http://www.sudoc.fr/247981869/id
is Author of	http://www.sudoc.fr/011391863/id 5,6-Epoxy-cholesterols contribute to the anticancer pharmacology of Tamoxifen in breast cancer cells. Auraptene is an inhibitor of cholesterol esterification and a modulator of estrogen receptors. One step synthesis of 6-oxo-cholestan-3β,5α-diol. The tumor-suppressor cholesterol metabolite, dendrogenin A, is a new class of LXR modulator activating lethal autophagy in cancers Exosomes account for vesicle-mediated transcellular transport of activatable phospholipases and prostaglandins. Ligand-dependent transcriptional induction of lethal autophagy: A new perspective for cancer treatment Microsomal antiestrogen-binding site ligands induce growth control and differentiation of human breast cancer cells through the modulation of cholesterol metabolism. Cholesterol epoxide hydrolase and cancer. Synthesis of new alkylaminooxysterols with potent cell differentiating activities: identification of leads for the treatment of cancer and neurodegenerative diseases. Flavonoids differentially modulate liver X receptors activity—Structure-function relationship analysis Signaling through cholesterol esterification: a new pathway for the cholecystokinin 2 receptor involved in cell growth and invasion. Cholesterol metabolism and resistance to tamoxifen. Oxysterols and related sterols: Implications in pharmacology and pathophysiology. Bryonolic Acid Blocks Cancer Cell Clonogenicity and Invasiveness through the Inhibition of Fatty Acid: Cholesteryl Ester Formation Identification of tyrosine 189 and asparagine 358 of the cholecystokinin 2 receptor in direct interaction with the crucial C-terminal amide of cholecystokinin by molecular modeling, site-directed mutagenesis, and structure/affinity studies. Development of a new radioligand for cholecystokinin receptor subtype 2 scintigraphy: from molecular modeling to in vivo evaluation. Improvement of 5,6α-epoxycholesterol, 5,6β-epoxycholesterol, cholestane-3β,5α,6β-triol and 6-oxo-cholestan-3β,5α-diol recovery for quantification by GC/MS Synthesis, characterization and in vitro evaluation of new oxorhenium- and oxotechnetium-CCK4 derivatives as molecular imaging agents for CCK2-receptor targeting. Cancer. Cholesterol and cancer, in the balance. http://www.sudoc.fr/245511695/id Dendrogenin A drives LXR to trigger lethal autophagy in cancers Molecular and Biochemical Analysis of the Estrogenic and Proliferative Properties of Vitamin E Compounds Importance of cholesterol and oxysterols metabolism in the pharmacology of tamoxifen and other AEBS ligands. Tamoxifen and AEBS ligands induced apoptosis and autophagy in breast cancer cells through the stimulation of sterol accumulation. Antiestrogen-binding site ligands induce autophagy in myeloma cells that proceeds through alteration of cholesterol metabolism Surprising unreactivity of cholesterol-5,6-epoxides towards nucleophiles. Identification of a tumor-promoter cholesterol metabolite in human breast cancers acting through the glucocorticoid receptor Cholesterol metabolism and cancer: the good, the bad and the ugly. Neutral Sphingomyelinase 2 Heightens Anti-Melanoma Immune Responses and Anti–PD-1 Therapy Efficacy https://serval.unil.ch/notice/serval:BIB_D1B3A2339998#id Targeting NR1H/liver X receptor with dendrogenin A differentiates tumor cells to activate a new secretory pathway releasing immunogenic anti-tumor vesicles enriched in LC3-II-associated exosomes Tamoxifen is a potent inhibitor of cholesterol esterification and prevents the formation of foam cells. A fast UPLC–HILIC method for an accurate quantiﬁcation of dendrogenin A in human tissues When cholesterol meets histamine, it gives rise to dendrogenin A: a tumour suppressor metabolite1 Technical note: Hapten synthesis, antibody production and development of an enzyme-linked immunosorbent assay for detection of the natural steroidal alkaloid Dendrogenin A. Exosomes as new vesicular lipid transporters involved in cell-cell communication and various pathophysiologies. Molecular characterization of the microsomal tamoxifen binding site. The novel steroidal alkaloids dendrogenin A and B promote proliferation of adult neural stem cells. https://hal.archives-ouvertes.fr/inserm-02380550#id Vitamin E: an overview Chemistry, biochemistry, metabolic fate and mechanism of action of 6-oxo-cholestan-3β,5α-diol (OCDO), a tumor promoter and cholesterol metabolite Is cholesterol a risk factor for breast cancer incidence and outcome? structure of cholecystokinin receptor binding sites and mechanism of activation/inactivation by agonists/antagonists The 5,6‐epoxycholesterol metabolic pathway in breast cancer: Emergence of new pharmacological targets Circulating oxysterol metabolites as potential new surrogate markers in patients with hormone receptor-positive breast cancer: Results of the OXYTAM study The 5,6‐epoxycholesterol metabolic pathway in breast cancer: Emergence of new pharmacological targets The Effects of Cholesterol-Derived Oncometabolites on Nuclear Receptor Function in Cancer Ligands of the antiestrogen-binding site induce active cell death and autophagy in human breast cancer cells through the modulation of cholesterol metabolism. Natural and semisynthetic oxyprenylated aromatic compounds as stimulators or inhibitors of melanogenesis Dendrogenin A Synergizes with Cytarabine to Kill Acute Myeloid Leukemia Cells In Vitro and In Vivo Insights into the cholecystokinin 2 receptor binding site and processes of activation. The 5,6-epoxycholesterol metabolic pathway in cancer: emergence of new pharmacological targets High tumorigenic potential of a constitutively active mutant of the cholecystokinin 2 receptor. HPLC Analysis and Skin Whitening Effects of Umbelliprenin-containing Extracts of Anethum Graveolens, Pimpinella Anisum, and Ferulago Campestris Quantitative analysis of the tumor suppressor dendrogenin A using liquid chromatography tandem mass spectrometry

Faceted Search & Find service v1.13.91 as of Aug 16 2018

Alternative Linked Data Documents: ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3229 as of May 14 2019, on Linux (x86_64-pc-linux-gnu), Single-Server Edition (70 GB total memory)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2024 OpenLink Software